Apomorphine, given subcutaneously (s.c.), induces erection and bladder overactivity in rats through stimulation of dopamine (D1-and D2-like) receptors in the central nervous system. In paraplegic patients, apomorphine was reported to cause bladder overactivity. This suggests that apomorphine may have a spinal site of action also for stimulation of erection. The present study was initiated to evaluate the effect of apomorphine on erectile function in spinalized rats. Apomorphine (100 mg=kg, s.c.) was given to awake, unrestrained male Sprague-Dawley rats (300 g) with or without spinal cord injury, made at the Th 8 level 2 weeks before the experiment. Intracavernous pressure changes from baseline were evaluated as time to first response to apomorphine (TFR; sec), number of phasic pressure changes in the first 30 min (PP30), duration (D; sec) of the phasic pressure changes, the amount of increase in tonic peak pressure (TPP; cmH 2 O), and burst peak pressure (BPP; cmH 2 O). Blood pressure (cmH 2 O) was recorded via an intra-arterial catheter. Apomorphine, 100 mg=kg, caused no significant differences in TFR (217.8 vs 271.2), PP30 (6.4 vs 6.5), D (38.9 vs 37.6.), TPP (51.0 vs 54.0) and BPP (128.9 vs 160.4) between normal (n ¼ 8) and spinalized rats (n ¼ 6). However, blood pressure decreased significantly more in spinalized than in normal animals (17.7 vs 43.3; P < 0.05). The results suggest that both in normal rats, and in rats with spinal cord injury, apomorphine given s.c., can produce erection. This finding supports the use of apomorphine for treatment of erectile dysfunction in paraplegia patients. However, due consideration should be given to possible decreases in blood pressure.
Introduction
Lal et al 1 showed in a placebo-controlled doubleblind study on healthy volunteers that apomorphine injected subcutaneously (s.c) was able to induce erection. However, side effects limited its usefulness as a treatment for erectile dysfunction (ED). Heaton et al 2 reported that apomorphine, absorbed through the oral mucosa, acted as an erectogenic agent in ED patients with few adverse effects. The beneficial effect of sublingual apomorphine in ED treatment was then confirmed in randomized, double-blind studies, 3 and sublingual apomorphine is currently an accepted treatment for ED.
Besides the erectile effect, s.c. apomorphine induces bladder overactivity in rats through stimulation of dopamine (D1-and D2-like) receptors in the central nervous system, 4 and in clinical studies, apomorphine has been shown to increase voiding efficacy in patients with Parkinson's disease. Steers et al 5 reported that sublingual apomorphine could improve bladder function in spinal cord injured patients. This implies that apomorphine may have a spinal site of action for stimulation of voiding. At the sacral level (S2 -S4), bladder parasympathetic preganglionic neurons (PGN) are located in the lateral part of the sacral intermediate gray matter. 6 These neurons also regulate reflex erection and change in blood flow in the genital area. Also entering the sacral level are sensory nerve impulses from the sex organs via both parasympathetic and somatic nerves. 7, 8 Giuliano et al 9 measured intracavernous pressure (ICP) and blood pressure in anesthetized rats receiving apomorphine intravenously (i.v.) and intrathecally (i.t.). Erections could be evoked by both ways of administration, implying that there may be dopaminergic receptors for erection at the spinal level. The authors suggested that the spinal site of action may participate in the generation of erection and exert a facilitatory effect on erection of supraspinal origin.
Intracavernous pressure monitoring in the awake rat is a useful approach to study drug effects on erectile function. 10 The aim of the present study was to evaluate the role of the spinal dopamine receptors for erection, using apomorphine in rats with chronic spinal injuries. Since clinical experiences from patients with Parkinson's disease have shown that apomorphine sometimes causes a decrease of blood pressure, 11 we also monitored this parameter.
The results of the study have previously been published in abstract from. 12 
Methods

Animals
Male Sprague-Dawley rats were used in this study. The weight of the normal animals (n ¼ 8) was 301.1 AE 3.7 g, and that of the spinally transected rats (n ¼ 6) was 287.5 AE 6.8 g (difference non-significant). The experimental protocol was approved by the Animal Ethics Committee, Shinshu University School of Medicine.
Spinal cord injury
The rats were divided into two groups: controls and animals with spinal transection (chronic spinal cord injury). Spinal transections were performed at the level of Th 8 -Th 9. 13,14 After a Th 8 -Th 9 laminectomy, the dura mater was opened, and under microscopic control, the spinal cord was transected completely using fine scissors under anesthesia with ketamine (Ketalar 1 , Parke Davis, Barcelona, Spain; 75 mg=kg, i.m.) and xylazine (Rompun 1 , Bayer AG, Leverkusen, Germany; 15 mg=kg, i.m.). Gelform was placed between the severed ends of the spinal cord. The dura mater and overlying muscle and skin were closed layer by layer.
Each rat was housed in a separate cage on a 12 h light=12 h dark photocycle. The animals were treated with antibiotics for 14 days. To prevent over-distension of the bladder, urine was expressed manually every 12 h until the time when the animal was to be subjected to investigation.
Intracavernous catheter implantation
Two weeks after the spinal transection, the spinal animals and their age-matched controls were anesthetized with sevoflurane (Sevofrane 1 , Nippon Hoechst Marion Roussel Ltd, Tokyo, Japan) and a midline scrotal incision was made. The proximal part of the right corpus cavernous was exposed after dissection of the ischiocavernous muscle. A polyethylene tubing (Clay-Adams PE-50), flushed with heparinized (100 IU=ml) saline (0.9%) solution and flanged at one end, was placed through the right crus of the penis into the cavernosal space, and then fixed with 6=0 propylene purse-string suture. An additional safety sealing was obtained by applying octyl cynoacrylate superglue (Nexaband 'Quick Seal', Veterinary Products Laboratories, Phoenix, AR, USA). After 10 min, the sealing was tested by flushing the tubing with saline. The tubing was brought out subcutaneously to the animals' back and fixed with 4=0 silk. The scrotal incision was closed with 5=0 propylene. Animals were allowed to recover for 1 h after the surgical procedure. To measure the intracavernous pressure, the PE-50 tubing was attached to a pressure transducer (P23 DC, Statham Instrument Inc, Oxnard, CA, USA) and connected to a multichannel pen-recorder. After completion of each experiment, the animal was checked for potential leakage from the cavernosal space. Animals exhibiting leakage were excluded from the study.
For arterial access to measure blood pressure, the common carotid artery was cannulated with PE-50 tubing that had been flushed with heparinized (100 IU=ml) saline solution. The tubing was brought out s.c. to the animals' back and fixed as described above for the intracavernous line. To measure blood pressure (BP), the PE-50 tubing was attached to a pressure transducer and connected to a multichannel pen-recorder. A polyethylene catheter (ClayAdams PE-50) was inserted into the subcutaneous space for administration of drugs.
Experimental procedure
After recovery from surgery, the animal was placed in a cage where it was connected to the pressure transducer and able to move. To induce an erection, apomorphine (100 mg=kg) dissolved in saline was given s.c. The dose of apomorphine was chosen on the basis of published data 15, 16 and our own pilot experiments.
Intracavernous pressure changes from baseline were evaluated as time to first response to apomorphine (TFR; sec), number of phasic pressure changes in the first 30 min (PP30), duration (D; sec) of the phasic pressure changes, the amount of increase in tonic peak pressure (TPP; cmH 2 O), and burst peak pressure (BPP; cmH 2 O).
Statistical analysis
Amplitude and duration of the responses were evaluated according to Figure 1 . 10 The results are
Effect of apomorphine O Ishizuka et al
given as mean values AE standard error of the mean. One way factorial ANOVA was used for comparisons between groups with regard to the drug effects. It was followed by Scheffe's F-test. A probability level of < 5% was accepted as significant.
Results
No spontaneous increases in intracavernous pressures were registered in the absence of apomorphine. In all animals, administration of apomorphine (100 mg=kg) induced the penile erection, stretching and yawning syndrome, well described by other investigators. It also produced repeated and transient increases of the ICP. The effect of apomorphine disappeared in about 120 min.
Administration of apomorphine (Figures 2 and 3 ), 100 mg=kg, caused no significant differences in time to first response (TFR; 217.8 AE 47. However, blood pressure decreased significantly more in spinalized than in control animals (17.7 AE 8.2 cmH 2 O vs 43.3 AE 7.9 cmH 2 O; P < 0.05).
Discussion
Dopaminergic mechanisms may be involved in the regulation of male sexual behavior. 17 Subcutaneous and centrally administered apomorphine, a dopamine receptor agonist which stimulates both dopamine D1-(D1 and D5) and D2-like (D2, D3, D4) receptors, has been shown to induce penile erection in rats. 18 Most studies on the effects of apomorphine rely on behavioral assessments. However, it has been demonstrated that apomorphine induced increases of intracavernous pressure and erection in an awake rat model. 10 The site of action of apomorphine is considered to be in the central nervous system, particularly the paraventricular nucleus of the hypothalamus (PVN). This has been shown by use of centrally acting dopamine receptor antagonists (haloperidol, sulpiride), which inhibit penile erection, whereas antagonists with only peripheral action fail to do so. 19 The view that the effects of apomorphine are not peripherally mediated is further supported by the finding that ablation of efferent nerve and blood supply to the corpora abolished erectile activity induced by systemic administration of apomorphine. Even at a high concentration (10 75 M), apomorphine failed to relax isolated rat penile corpus cavernosum (Andersson et al, unpublished information). The fact that the effects of apomorphine were abolished after NO synthase inhibition suggests that the apomorphine action is dependent on release of NO, possibly at both central and peripheral sites. 7, 20 The present study clearly demonstrated the importance of the spinal site of action of apomorphine, since after s.c. administration the changes in ICP in the normal and spinally transected rats were almost the same. It has been shown that the erectile effect of systemically administered apomorphine can be blocked by oxytocin receptor antagonists given intracerebroventricularly, implying that dopamine receptor stimulation involves release of oxytocin, at least at the central level. 21 Oxytocin given i.t. in rats has a proerectile effect. 22, 23 However, it is unclear whether the apomorphine action at the spinal level is dependent on oxytocin release.
In the present study, apomorphine decreased blood pressure, especially in the rats with spinal cord injury. Llau et al 11 reported that s.c. administered apomorphine caused orthostatic hypotension in Parkinson's disease patients. Lahlou and Demenge 24 also reported, using rat models, that complete spinal transection increased the hypotensive responses to dopaminergic stimulation by i.t. apomorphine.
These results show that in both normal rats, and non-anesthetized rats with chronic spinal cord injury, apomorphine given s.c. can produce erection. This finding suggests that apomorphine can be effective for treatment of ED in paraplegia patients. However, we used s.c. administration, which is known to produce higher systemic blood (and CNS) concentrations than when the drug is given sublingually, which is the clinically used administration 
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O Ishizuka et al Figure 2 Tracing showing intracavernous pressure and blood pressure response in control awake rats to subcutaneous apomorphine (100 mg=kg). Figure 3 Tracing showing intracavernous pressure and blood pressure response in awake rats with spinal cord injury to subcutaneous apomorphine (100 mg=kg).
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form. Furthermore, due consideration should be given to possible decreases in blood pressure if apomorphine is given to patients with spinal cord injuries.
